Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 60
15
Diseases
40
Unique genes
0.302
Avg. similarity score
Mitral valve disease
Most-connected disease (9 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Mitral valve disease
Cervical dysplasia
Microvascular angina
homocystinuria due to methylene tetrahydrofolate reductase deficiency
Rheumatic disease of mitral valve
Rheumatic mitral regurgitation
Uterine disease
Coronary restenosis
renal tubular dysgenesis - ACE
Ataxia with intention tremor and hypotonia
Cerebellar dysfunction with variable cognitive and behavioral abnormalities
Fabry disease
Portal vein thrombosis
Carotid artery stenosis
krabbe disease
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Mitral valve disease | 9 | 9 | 2 |
| Cervical dysplasia | 7 | 7 | 2 |
| Microvascular angina | 7 | 7 | 1 |
| homocystinuria due to methylene tetrahydrofolate reductase deficiency | 7 | 7 | 1 |
| Rheumatic disease of mitral valve | 6 | 6 | 2 |
| Rheumatic mitral regurgitation | 6 | 6 | 2 |
| Uterine disease | 6 | 6 | 2 |
| Coronary restenosis | 4 | 4 | 14 |
| renal tubular dysgenesis - ACE | 4 | 4 | 1 |
| Ataxia with intention tremor and hypotonia | 3 | 3 | 1 |
| Cerebellar dysfunction with variable cognitive and behavioral abnormalities | 3 | 3 | 6 |
| Fabry disease | 3 | 3 | 9 |
| Portal vein thrombosis | 3 | 3 | 3 |
| Carotid artery stenosis | 1 | 1 | 13 |
| krabbe disease | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| MTHFR | 10 / 15 | Carotid artery stenosis, Cervical dysplasia, Coronary restenosis, homocystinuria due to methylene tetrahydrofolate reductase deficiency and 6 more |
| ACE | 6 / 15 | Coronary restenosis, Fabry disease, Mitral valve disease, renal tubular dysgenesis - ACE and 2 more |
| POU4F1 | 4 / 15 | Ataxia with intention tremor and hypotonia, Cerebellar dysfunction with variable cognitive and behavioral abnormalities, Cervical dysplasia, Uterine disease |
| GALC | 2 / 15 | Fabry disease, krabbe disease |
| MMP3 | 2 / 15 | Carotid artery stenosis, Coronary restenosis |
| SPP1 | 2 / 15 | Carotid artery stenosis, Coronary restenosis |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Interleukin-4 and Interleukin-13 signaling | Reactome | 7 / 108 | 19.5× | 5.71e-8 | 4.01e-6 ✓ sig. |
| Coronavirus disease - COVID-19 | KEGG | 7 / 238 | 8.8× | 1.17e-5 | 3.83e-4 ✓ sig. |
| Rheumatoid arthritis | KEGG | 5 / 95 | 15.8× | 1.47e-5 | 4.63e-4 ✓ sig. |
| Degradation of the extracellular matrix | Reactome | 4 / 70 | 17.2× | 8.25e-5 | 1.92e-3 ✓ sig. |
| Complement and coagulation cascades | KEGG | 4 / 88 | 13.6× | 2.01e-4 | 3.92e-3 ✓ sig. |
| AGE-RAGE signaling pathway in diabetic complications | KEGG | 4 / 101 | 11.9× | 3.41e-4 | 5.93e-3 ✓ sig. |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | Reactome | 4 / 125 | 9.6× | 7.65e-4 | 1.11e-2 ✓ sig. |
| Regulation of TP53 Activity through Association with Co-factors | Reactome | 2 / 14 | 42.9× | 9.60e-4 | 1.32e-2 ✓ sig. |
| Mineral absorption | KEGG | 3 / 61 | 14.8× | 1.08e-3 | 1.44e-2 ✓ sig. |
| Apelin signaling pathway | KEGG | 4 / 140 | 8.6× | 1.17e-3 | 1.52e-2 ✓ sig. |
| Fluid shear stress and atherosclerosis | KEGG | 4 / 141 | 8.5× | 1.20e-3 | 1.55e-2 ✓ sig. |
| Metabolism of Angiotensinogen to Angiotensins | Reactome | 2 / 17 | 35.3× | 1.43e-3 | 1.77e-2 ✓ sig. |
| PPAR signaling pathway | KEGG | 3 / 76 | 11.9× | 2.03e-3 | 2.31e-2 ✓ sig. |
| Pertussis | KEGG | 3 / 78 | 11.5× | 2.19e-3 | 2.44e-2 ✓ sig. |
| Leishmaniasis | KEGG | 3 / 78 | 11.5× | 2.19e-3 | 2.44e-2 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| regulation of renal output by angiotensin | GO:0002019 | 2 / 2 | 467× | 4.47e-6 | 2.74e-4 ✓ sig. |
| response to glucocorticoid | GO:0051384 | 4 / 53 | 35.3× | 4.89e-6 | 2.95e-4 ✓ sig. |
| negative regulation of blood coagulation | GO:0030195 | 3 / 16 | 87.6× | 4.99e-6 | 3.00e-4 ✓ sig. |
| positive regulation of calcineurin-NFAT signaling cascade | GO:0070886 | 3 / 21 | 66.7× | 1.18e-5 | 5.92e-4 ✓ sig. |
| positive regulation of mitochondrial membrane permeability | GO:0035794 | 2 / 3 | 311× | 1.34e-5 | 6.55e-4 ✓ sig. |
| extracellular matrix organization | GO:0030198 | 5 / 145 | 16.1× | 1.39e-5 | 6.74e-4 ✓ sig. |
| decidualization | GO:0046697 | 3 / 25 | 56.1× | 2.02e-5 | 9.06e-4 ✓ sig. |
| positive regulation of angiogenesis | GO:0045766 | 5 / 159 | 14.7× | 2.17e-5 | 9.56e-4 ✓ sig. |
| negative regulation of proteolysis | GO:0045861 | 3 / 27 | 51.9× | 2.56e-5 | 1.08e-3 ✓ sig. |
| response to macrophage colony-stimulating factor | GO:0036005 | 2 / 4 | 234× | 2.67e-5 | 1.12e-3 ✓ sig. |
| positive regulation of protein-containing complex disassembly | GO:0043243 | 2 / 4 | 234× | 2.67e-5 | 1.12e-3 ✓ sig. |
| maintenance of blood vessel diameter homeostasis by renin-angiotensin | GO:0002034 | 2 / 5 | 187× | 4.45e-5 | 1.65e-3 ✓ sig. |
| cellular extravasation | GO:0045123 | 2 / 5 | 187× | 4.45e-5 | 1.65e-3 ✓ sig. |
| cellular response to lipopolysaccharide | GO:0071222 | 5 / 187 | 12.5× | 4.71e-5 | 1.72e-3 ✓ sig. |
| positive regulation of reactive oxygen species metabolic process | GO:2000379 | 3 / 34 | 41.2× | 5.19e-5 | 1.85e-3 ✓ sig. |